LC
CL icon

Lindbrook Capital’s Colgate-Palmolive CL Stock Holding History

Lindbrook Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$843K Buy
8,992
+2,596
+41% +$232K 0.08% 151
2024
Q4 		$581K Sell
6,396
-39
-0.6% -$3.72K 0.05% 200
2024
Q3 		$668K Buy
6,435
+38
+0.6% +$3.87K 0.06% 183
2024
Q2 		$621K Buy
6,397
+105
+2% +$9.69K 0.06% 178
2024
Q1 		$567K Buy
6,292
+184
+3% +$15.6K 0.05% 200
2023
Q4 		$487K Buy
6,108
+1,956
+47% +$147K 0.05% 204
2023
Q3 		$295K Sell
4,152
-756
-15% -$56.5K 0.03% 248
2023
Q2 		$378K Buy
4,908
+233
+5% +$18K 0.04% 221
2023
Q1 		$351K Buy
4,675
+1,559
+50% +$116K 0.04% 218
2022
Q4 		$246K Buy
3,116
+48
+2% +$3.6K 0.03% 287
2022
Q3 		$216K Buy
3,068
+56
+2% +$4.39K 0.04% 258
2022
Q2 		$241K Buy
3,012
+764
+34% +$59.7K 0.04% 245
2022
Q1 		$170K Buy
2,248
+392
+21% +$31.1K 0.03% 326
2021
Q4 		$158K Buy
1,856
+980
+112% +$76.5K 0.02% 364
2021
Q3 		$66K Sell
876
-151
-15% -$12K 0.02% 365
2021
Q2 		$84K Buy
1,027
+25
+2% +$2.04K 0.02% 329
2021
Q1 		$79K Buy
1,002
+42
+4% +$3.29K 0.02% 317
2020
Q4 		$82K Buy
960
+39
+4% +$3.23K 0.02% 279
2020
Q3 		$71K Sell
921
-52
-5% -$3.96K 0.02% 272
2020
Q2 		$71K Buy
973
+97
+11% +$6.89K 0.02% 277
2020
Q1 		$58K Sell
876
-14
-2% -$987 0.02% 284
2019
Q4 		$61K Sell
890
-53
-6% -$3.61K 0.02% 382
2019
Q3 		$69K Buy
943
+30
+3% +$2.18K 0.03% 318
2019
Q2 		$65K Buy
913
+95
+12% +$6.74K 0.03% 340
2019
Q1 		$56K Buy
818
+202
+33% +$13K 0.02% 364
2018
Q4 		$36K Buy
+616
New +$38.5K 0.02% 440

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Lindbrook Capital's CL Position: Q1 2025 in Review

Lindbrook Capital increased its Colgate-Palmolive (CL) stake by 41% in Q1 2025, buying an estimated $232K and bringing the position to 8,992 shares worth $843K. The position accounts for 0.08% of the portfolio, ranked #151.

Lindbrook Capital first reported a position in CL in Q4 2018 and has held it in 26 quarters since. 1,943 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Lindbrook Capital held 8,992 shares of Colgate-Palmolive worth $843K as of Q1 2025.
  • Lindbrook Capital bought 2,596 Colgate-Palmolive shares in Q1 2025, an estimated $232K.
  • Colgate-Palmolive made up 0.08% of Lindbrook Capital's portfolio in Q1 2025, its #151 holding.
  • Lindbrook Capital first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 26 quarters since.
  • 1,943 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.